The impact of gabapentin on muscle cramps throughout hemodialysis: A double-blind scientific trial Beladi Mousavi SS, Zeraati A, Moradi S, Mousavi MB

The effect of gabapentin on muscle cramps during hemodialysis: A double-blind clinical trial Beladi Mousavi SS, Zeraati A, Moradi S, Mousavi MB
December 22, 2020 0 Comments

   Summary  

Hemodialysis‐related muscle cramps (HAMC) are a typical complication throughout hemodialysis (HD) classes. Quite a lot of pharmacologic brokers have been evaluated to forestall and or diminish HAMC; nevertheless, none of them has a longtime position. To one of the best of our data, that is the primary research to guage the attainable impact of gabapentin on HAMC. In a double-blinded scientific trial, we in contrast the attainable impact of gabapentin with a placebo in prevention and or diminishing episodes of HAMC in HD sufferers who had skilled frequent intradialytic muscle cramps. At first, placebo was given earlier than every dialysis session for 4 weeks after which, after a two-week washout interval, 300 mg of gabapentin was given earlier than every dialysis session for 4 weeks to confirm the impact of gabapentin on HAMC. Total, 15 sufferers (seven males and eight ladies; imply age, 52.02 years) with frequent intradialytic muscle cramps had been enrolled within the research. The incidence of symptomatic muscle cramp decreased within the gabapentin group in contrast with the placebo group, with a big distinction between them (P = 0.001). The depth of muscle cramps additionally decreased within the gabapentin group (P = 0.001). There was no vital affiliation between HAMC in female and male sufferers (P = 0. 397), imply age of HD sufferers (P = 0.226) and explanation for end-stage renal illness (P = 0.551). In keeping with the outcomes of our research, gabapentin prescription earlier than every HD session considerably lowered the frequency and the depth of muscle cramps throughout HD with none main side-effects.

The right way to cite this text:
Beladi Mousavi SS, Zeraati A, Moradi S, Mousavi MB. The impact of gabapentin on muscle cramps throughout hemodialysis: A double-blind scientific trial. Saudi J Kidney Dis Transpl 2015;26:1142-8

The right way to cite this URL:
Beladi Mousavi SS, Zeraati A, Moradi S, Mousavi MB. The impact of gabapentin on muscle cramps throughout hemodialysis: A double-blind scientific trial. Saudi J Kidney Dis Transpl [serial online] 2015 [cited 2020 Dec 22];26:1142-8. Out there from: https://www.sjkdt.org/textual content.asp?2015/26/6/1142/168588

   Introduction   Top

Though life expectancy and survival of sufferers with end-stage renal illness (ESRD) has improved for the reason that introduction of hemodialysis (HD) within the early Fifties, many problems with a number of and poorly understood underlying mechanisms generally happen throughout HD remedy. A few of them embody hemodialysis-associated muscle cramps (HAMC), hypotension throughout HD, ventricular and supraventricular arrhythmias, nausea and vomiting, chest and again ache, headache, itching, allergic reactions to dialyzer or medicines and fever and chills. [1],[2],[3],[4],[5],[6]

Muscle cramps are extended involuntary and infrequently painful contraction of the muscular tissues that always happen within the muscular tissues. They’re widespread in adults and virtually everybody experiences a muscle cramp at a while of their life. Muscle cramps are additionally an vital and customary complication of HD that happen in about 3580% of HD sufferers. [7],[8],[9] It mostly includes the muscular tissues of the decrease limb; nevertheless, different muscular tissues together with the arms, arms and stomach can also be affected throughout HD. The severity of cramps occurring with dialysis remedy could also be very excessive and subsequently it has a big detrimental influence on health-related high quality of life amongst HD sufferers. In some sufferers, it may be extreme sufficient to necessitate discontinuation of HD and it’s reported as the most typical explanation for stopping HD and a big explanation for underdialysis. [7],[8],[9]

Totally different methods and variety of pharmacologic brokers have been evaluated to forestall and/or diminish the severity of HAMC; nevertheless, due to a small variety of comparative research having conflicting outcomes, there aren’t any usually accepted pointers for the prevention of muscle cramps throughout HD.

The purpose of this research was to guage the attainable impact of gabapentin for the prevention of HAMC episodes and/or diminishing the severity of muscle cramps throughout HD.

   Supplies and Strategies   Top

Examine design

The research was a cross-sectional, double-blind, and managed scientific trial that was authorised by the Ethics Committee of the Power Renal Failure Analysis Middle of the Ahvaz Jundishapur College of Medical Sciences.

We used a standardized questionnaire to gather basic data comparable to age, gender, important indicators, causes of ESRD, date of onset of HD and size of time receiving HD companies, the document of earlier medication and the incidence and depth of intradialytic muscle cramps.

A muscular cramp episode was outlined as a painful involuntary muscle contraction that lasted for greater than 1 min throughout HD.

The drug and placebo had been supplied to the sufferers freed from price by the Power Renal Failure Analysis Middle. The interval of research was 4 months from March 2011 to August 2011. The character of the scientific trial was defined to the HD sufferers and written knowledgeable consents had been obtained from them. The aim of the research was discount of the HAMC episodes. Major finish factors of the research had been prevention of HAMC episodes and/or diminishing the severity of muscle cramps throughout HD.

Sufferers

The research was carried out on ESRD sufferers who had been present process HD therapies on the Imam Hospital, Ahvaz, Southwestern Iran. ESRD was outlined as everlasting and irreversible superior lack of kidney perform because of any trigger with creatinine clearance <10-15 mL/min/1.73 m 2 requiring upkeep HD remedy.

All HD sufferers had been monitored for one month and sufferers with six episodes of intradialytic muscle cramp per thirty days or extra had been included within the research and people with the next traits had been excluded: Electrolyte disturbance, hemodynamic instability throughout HD and sufferers who had used different safety measure for prevention of muscle cramp comparable to vitamin E, benzodiazepine, quinine sulfate, hypertonic sodium and or bicarbonate answer.

Drug administration

This research was carried out in three levels:

  1. Placebo administration (1 month) within the first month of the research.
  2. Washout interval (2 weeks later).
  3. Gabapentin administration (1 month after the washout interval).

By utilizing a double-blind protocol, placebo and 300 mg gabapentin was administrated to sufferers 5 min earlier than beginning HD. The prevalence of painful muscle cramp episodes and severity of this complication was recorded throughout these three levels. Severity of HAMC recorded was based mostly on numerical measurement by asking sufferers (0 = painless, 10 = extreme ache). [10] To ensure that any modifications noticed had been associated to the administration of gabapentin, this drug was administrated throughout the third stage.

Hemodialysis strategies

HD was carried out for 9-12 h, three or 4 instances per week utilizing Fresenius machines. We used artificial (polysulfone) dialyzer membranes and bicarbonate-buffered dialysate for all our sufferers. The opposite traits of dialysate had been sodium 135-140 mmol/L, potassium 2 mmol/L and calcium 1.5 mmol/L, magnesium 0.5 mmol/L and bicarbonate 35- 40 mmol/L. Blood movement price and dialysate movement price had been maintained at 250-400 mL/min and 500 mL/min, respectively. Dialysate temperature was 36.58°C (97.84°F) throughout HD. The speed of ultrafiltration throughout every HD session was decided individually by the nephrologist in keeping with scientific analysis.

   Statistical evaluation   Top

Outcomes are expressed as imply ± SD. Distinction between two levels (gabapentin and placebo administration) was analyzed by Pupil’s paired T check. We used the SPSS model 15 software program for statistical evaluation. A P-value <0.05 had been thought of vital.

   Outcomes   Top

Sufferers on this research consisted of eight females and 7 males, with a mean age of 52.02 years. No sufferers expired throughout this research. The reason for end-stage renal dialysis in eight topics was hypertension, diabetes mellitus in three topics and glomerulonephritis in 4 topics. Frequency of dizziness, nausea, stupor and ataxia was not elevated throughout the gabapentin interval and the drug was tolerated very properly.

The information gathered from the question varieties had been analyzed utilizing the SPSS program. Earlier than making use of any type of knowledge analyzing check, the normality of distribution of our check group was verified. By utilizing the one-sample Kolmogorov- Smirnov check, the normality of distribution was rejected (P = 0.392, SD = 1.207). Subsequently, we used non-parametric assessments.

Based mostly on the outcomes of two associated pattern assessments after one month of gabapentin prescription, the frequency of muscle cramp episodes decreased between 20% and 100% in all topics.

The check end result (P <0.001) confirmed a big distinction within the frequency of muscle cramps. 5 sufferers (30%) turned completely symptom free. Comparatively talking, in 93.3% of the themes, muscle cramp frequency was decreased by greater than 60%. The frequency of muscle cramp episodes is proven in [Table 1].

Desk 1: The frequency of muscle cramp episodes throughout placebo and gabapentin intervals.

Click on right here to view

Based mostly on the outcomes of two associated samples check (signal check) throughout the gabapentin interval, the depth of muscle cramps in all check topics was decreased (P <0.001) [Table 2]. The frequency and variance of muscle cramp depth is proven in [Table 3]. Take a look at topics had proven a 12-100% lower of the muscle cramp depth throughout the gabapentin interval.

Desk 2: Comparability of muscle cramp depth throughout the placebo and gabapentin intervals.

Click on right here to view

Desk 3: Common of muscle cramp depth throughout the placebo and gabapentin intervals.

Click on right here to view

Distinction in frequency (P = 1.00) and depth (P = 0.581) of muscle cramps between placebo intervals and earlier than remedy had been examined and there was no vital distinction.

   Dialogue   Top

Muscle cramps trigger numerous bodily and psychological downside in HD sufferers. Though pathogenesis and precise mechanism of HAMC are nonetheless unknown, a number of of the next components together with hypovolemia, hyponatremia, tissue hypoxia, hypomagnesemia, carnitine deficiency and elevated serum leptin ranges could also be implicated within the improvement of intradialysis muscle cramping.

As a result of HAMCs happen most regularly close to the top of the HD session, it appears that evidently from the above components, plasma quantity contraction and modifications in plasma osmolality, both alone or together, are the probably underlying mechanisms of this complication. [10],[11],[12],[13],[14],[15],[16]

Therapy of cramps occurring throughout dialysis remedy is aimed toward two objectives: (i) attainable interventions to forestall the cramps and (ii) discount of the frequency of cramps and relieving signs once they happen. [17]

In keeping with the vital position of hypovolemia and modifications in plasma osmolality within the improvement of muscle cramp throughout HD, methods such because the prevention of dialysis-associated hypotension, the minimization of interdialytic weight features to keep away from excessive charges of ultrafiltration required to attain the affected person’s dry weight throughout HD and the usage of excessive concentrations of sodium within the dialysate are the extra usually accepted measures for prevention of HAMC. [9],[17],[18],[19],[20]

Nonetheless, in a considerable variety of sufferers, HAMCs usually are not fully prevented by these methods. As well as, these measures can’t be utilized in many sufferers, particularly in these sufferers who’re in want of ultrafiltration throughout HD. [17] Subsequently, it’s obligatory to guage another methods and pharmacologic brokers for the prevention or discount of the frequency of dialysis-associated cramps.

Gabapentin, a structural analogue of GABA, is a brand new and secure anticonvulsive drug that can also be used for quite a lot of completely different situations. It has been demonstrated that gabapentin reduces neuropathic ache whereas additionally lowering irregular neural excretion and rising verge of nerve activation. [21] Within the administration of neuropathic ache, gabapentin is a lovely therapeutic possibility in contrast with different anticonvulsants, tricyclic antidepressants and opioids due to its relative lack of interactions and critical adversarial results.

Small research have additionally urged that gabapentin can also be efficient for muscle cramps. [22] Nonetheless, to one of the best of our data, we didn’t discover any research that had evaluated the attainable impact of gabapentin on HAMC amongst HD sufferers.

Our research exhibits that gabapentin at a dose of 300 mg orally 5 min earlier than beginning HD can considerably cut back the frequency of muscle cramp episodes throughout HD between 20% and 100% in all topics. As well as, the info from our scientific trial additionally confirmed that the depth of muscle cramps is decreased by way of gabapentin.

In a small, open-label scientific trial, Mariano et al evaluated the efficacy and security of gabapentin amongst 30 non-uremic sufferers with frequent (>5 cramps/week) and long-lasting muscle cramps. They discovered {that a} dose of 600 mg/d of gabapentin is efficient in decreasing the frequency and severity of muscle cramps inside two weeks. After three months of remedy with a imply dosage of 892 ± 180 mg, muscle cramps disappeared in the entire sufferers and the therapeutic impact of gabapentin endured so long as six months. [22]

Compared to the Mariano et al research, the dosage of gabapentin utilized in our trial was at a decrease dosage. We administered the drug at a dosage of 300 mg solely 3 times per week 5 min earlier than beginning HD. The elimination half-life of gabapentin is 5-7 h, and it’s eradicated unchanged from the systemic circulation by renal excretion. [23],[24],[25],[26] Amongst sufferers present process HD, particularly in anuric topics, the elimination half-life is elevated to about 132 h on non-HD days. [27] Subsequently, the dosage of gabapentin, as we did, ought to be lowered amongst sufferers with compromised renal perform or these present process dialysis.

In our research, gabapentin was properly tolerated and was not related to any side-effects. It seems that it could be as a result of time of administration of gabapentin in our research (earlier than every HD). Though the elimination half-life of gabapentin may be very lengthy in uremic sufferers, HD has a big impact on gabapentin elimination and the obvious half-life is lowered to three.8 h throughout dialysis days. [27]

Though gabapentin didn’t induce any reported adversarial impact in our trial, it’s recognized to be related to a number of side-effects, together with somnolence, dizziness, asthenia, ataxia and fatigue. [28],[29] For instance, by reviewing knowledge from managed scientific trials, Ramsay reported that the most typical side-effects of gabapentin are somnolence, dizziness, asthenia, ataxia and fatigue, which occurred in 20%, 18%, 13% and 11% of sufferers, respectively. [28]

In a big open-label multicenter research, McLean et al evaluated the tolerability and security of gabapentin as an adjunctive remedy for seizure management amongst 2216 sufferers throughout a interval of 16 weeks. They confirmed that gabapentin can induce somnolence, dizziness and asthenia in 15.2%, 10.9% and 6.0% of sufferers, respectively. Probably the most critical adversarial impact of gabapentin within the research of McLean et al was convulsions, which occurred in 0.9% of sufferers. [29]

Along with the above-mentioned side-effects, case reviews have urged that gabapentin might trigger reversible acute renal allograft dysfunction by a mechanism involving renal afferent vasoconstriction and critical pores and skin eruptions comparable to Stevens-Johnson’s syndrome. [30],[31] It is a beneficial data to be saved in thoughts by the nephrologists whereas treating post-renal transplant sufferers.

   Conclusion   Top

HAMCs are an vital and customary complication of HD having a big detrimental influence on health-related high quality of life amongst HD sufferers.

Our research exhibits that gabapentin, a brand new and secure anticonvulsive drug at a dose of 300 mg orally 5 min earlier than beginning HD, can considerably cut back the frequency and the depth of muscle cramps throughout HD with none main side-effects. Though the outcomes of our research are fascinating, our research is restricted by the quick length and small variety of sufferers enrolled within the research. As well as, our research was a single-center research. Multi-center scientific trials with an extended length and bigger variety of sufferers are wanted to additional consider the impact of gabapentin for the prevention and discount of the depth of muscle cramps throughout HD.

   Acknowledgements   Top

This paper is issued from the thesis of Dr. Sajad Moradi and monetary help was supplied by the Power Renal Failure Analysis Middle of the Ahvaz Jundishapur College of Medical Sciences. The authors want to thank Miss Perisa Shehni and the workers and ESRD sufferers within the HD middle of Imam Hospital within the province of Khuzestan, Ahvaz, Iran for assist with this work.

 

   References   Top

1.
Beladi Mousavi SS, Alemzadeh Ansari MJ, Cheraghian B. End result of sufferers on haemodialysis in Khuzestan, Iran. NDT Plus 2011;4:143-4.  Back to cited text no. 1
    
2.
Beladi-Mousavi SS, Alemzadeh-Ansari MJ, Alemzadeh-Ansari MH, Beladi-Mousavi M. Lengthy-term survival of sufferers with end-stage renal illness on upkeep hemodialysis: A multicenter research in Iran. Iran J Kidney Dis 2012;6:452-6.  Back to cited text no. 2
    
3.
Skroeder NR, Jacobson SH, Lins LE, Kjellstrand CM. Acute signs throughout and between hemodialysis: The relative position of velocity, length, and biocompatibility of dialysis. Artif Organs 1994;18:880-7.  Back to cited text no. 3
    
4.
van der Sande FM, Kooman JP, Leunissen KM. Intradialytic hypotension – New ideas on an outdated downside. Nephrol Dial Transplant 2000;15:1746-8.  Back to cited text no. 4
[PUBMED]    
5.
Skroeder NR, Jacobson SH, Lins LE, Kjellstrand CM. Biocompatibility of dialysis membranes is of no significance for goal or subjective signs throughout or after hemodialysis. ASAIO Trans 1990;36:M637-9.  Back to cited text no. 5
    
6.
Milinkovic M, Zidverc-Trajkovic J, Sternic N, et al. Hemodialysis headache. Clin Nephrol 2009;71:158-63.  Back to cited text no. 6
    
7.
Ahmad S, Robertson HT, Golper TA, et al. Multicenter trial of L-carnitine in upkeep hemodialysis sufferers. II. Scientific and biochemical results. Kidney Int 1990;38:912-8.  Back to cited text no. 7
    
8.
Rocco MV, Burkart JM. Prevalence of missed therapies and early sign-offs in hemodialysis sufferers. J Am Soc Nephrol 1993;4:1178-83.  Back to cited text no. 8
    
9.
Canzanello VJ, Burkart JM. Hemodialysis-associated muscle cramps. Semin Dial 1992;5:299.  Back to cited text no. 9
    
10.
Kobrin SM, Berns JS. Quinine – A tonic too bitter for hemodialysis-associated muscle cramps? Semin Dial 2007;20:396-401.  Back to cited text no. 10
    
11.
Pateman JA. Measurement of ache. In: Dolin SP, Nicholas PJ, eds. Ache Clinic Guide. New York: Butter Price-Heinemann; 1996. p. 12.  Back to cited text no. 11
    
12.
McGee SR. Muscle cramps. Arch Intern Med 1990;150:511-8.  Back to cited text no. 12
    
13.
Hung CY, Chen YL, Chen CS, Yang CS, Peng SJ. Affiliation of leptin with hemodialysis-related muscle cramps: A cross-sectional research. Blood Purif 2009;27:159-64.  Back to cited text no. 13
    
14.
Tamadon MR, Beladi Mousavi SS. Erythropoietin: a Assessment on Present Information and New Ideas. J Ren Inj Prev 2013;2(4):119-21.  Back to cited text no. 14
    
15.
Jansen PH, Veenhuizen KC, Wesseling AI, de Boo T, Verbeek AL. Randomised managed trial of hydroquinine in muscle cramps. Lancet 1997;349:528-32.  Back to cited text no. 15
    
16.
Mandal AK, Abernathy T, Nelluri SN, Stitzel V. Is quinine efficient and secure in leg cramps? J Clin Pharmacol 1995;35:588-93.  Back to cited text no. 16
    
17.
Mujais SK. Muscle cramps throughout hemodialysis. Artif Organs 1993;779:570-2.  Back to cited text no. 17
    
18.
Sang GL, Kovithavongs C, Ulan R, Kjellstrand CM. Sodium ramping in hemodialysis: a research of useful and adversarial results. Am J Kidney Dis 1997;29:669-77.  Back to cited text no. 18
    
19.
Ok/DOQI Workgroup. Ok/DOQI scientific observe pointers for heart problems in dialysis sufferers. Am J Kidney Dis 2005;45 4 Suppl 3:S1-153.  Back to cited text no. 19
    
20.
Tune JH, Park GH, Lee SY, Lee SW, Lee SW, Kim MJ. Impact of sodium stability and the mixture of ultrafiltration profile throughout sodium profiling hemodialysis on the upkeep of the standard of dialysis and sodium and fluid balances. J Am Soc Nephrol 2005;16: 237-46.  Back to cited text no. 20
    
21.
Yoon MH, Yaksh TL. The impact of intrathecal gabapentin on ache habits and hemodynamics on the formalin check within the rat. Anesth Analg 1999;89:434-9.  Back to cited text no. 21
    
22.
Mariano S, Paolo R, Patrizio C, Gabriele V, Leoluca P, Francesco P. Gabapentin remedy for muscle cramps: An open-label trial. Clin Neuropharmacol 2000;23:45-9.  Back to cited text no. 22
    
23.
Richens A. Scientific pharmacokinetics of gabapentin. In: Chadwick D, editor. New Tendencies in Epilepsy Administration: The Position of Gabapentin. London: Royal Society of Medication; 1993. p. 41-6.  Back to cited text no. 23
    
24.
Hooper WD, Kavanagh MC, Herkes GK, Eadie MJ. Lack of a pharmacokinetic interplay between phenobarbitone and gabapentin. Br J Clin Pharmacol 1991;31:171-4.  Back to cited text no. 24
    
25.
Comstock TJ, Sica DA, Bockbrader HN, Underwood BA, Sedman AJ. Gabapentin pharmacokinetics in sufferers with numerous levels of renal perform. J Clin Pharmacol 1990;30:862.  Back to cited text no. 25
    
26.
Hooper WD, Kavanagh MC, Dickinson RG. Willpower of gabapentin in plasma and urine by capillary column fuel chromatography. J Chromatogr 1990;529:167-74.  Back to cited text no. 26
    
27.
Wong MO, Eldon MA, Keane WF, et al. Disposition of gabapentin in anuric topics on hemodialysis. J Clin Pharmacol 1995;35:622-6.  Back to cited text no. 27
    
28.
Ramsay RE. Gabapentin toxicity. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic Medication. 4th ed. New York: Raven Press; 1995. p. 857-60.  Back to cited text no. 28
    
29.
McLean MJ, Morrell MJ, Willmore LJ, et al. Security and tolerability of gabapentin as adjunctive remedy in a big, multicenter research. Epilepsia 1999;40:965-72.  Back to cited text no. 29
    
30.
Gallay BJ, de Mattos AM, Norman DJ. Reversible acute renal allograft dysfunction because of gabapentin. Transplantation 2000;70: 208-9.  Back to cited text no. 30
    
31.
Gonzalez-Sicilia L, Cano A, Serrano M, Hernandez J. Stevens-Johnson syndrome related to gabapentin. Am J Med 1998;105: 455.  Back to cited text no. 31
    


Top

Correspondence Handle:
Abbasali Zeraati
Division of Nephrology, Imam Reza Hospital, Mashhad College of Medical Sciences, Mashhad
Iran
Login to access the Email id

Crossref citations Test

DOI: 10.4103/1319-2442.168588

PMID: 26586051

Rights and Permissions

 
 

 
[Table 1], [Table 2], [Table 3]

Leave a Reply

Your email address will not be published. Required fields are marked *